{"id":58151,"date":"2020-09-24T18:30:31","date_gmt":"2020-09-24T21:30:31","guid":{"rendered":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/"},"modified":"2020-09-24T18:30:31","modified_gmt":"2020-09-24T21:30:31","slug":"russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil","status":"publish","type":"post","link":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/","title":{"rendered":"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil"},"content":{"rendered":"<p style=\"text-align: justify;\">Nesta quinta-feira (24), o fundo soberano da R\u00fassia e o grupo farmac\u00eautico KhimRar, sediado em Moscou, anunciou que foi firmado um acordo para a venda de um medicamento antiviral contra a Covid-19 para 17 pa\u00edses, entre ele o Brasil.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">De acordo com o fundo soberano da R\u00fassia, a Avifavir \u00e9 a primeira droga baseada em favipiravir do mundo a ser aprovada para o tratamento da Covid-19, e que o composto \u00e9 usado desde 2014 no Jap\u00e3o contra a gripe, com o nome comercial de Avigan.<\/p>\n<p style=\"text-align: justify;\">Entre os pa\u00edses que ir\u00e3o receber o medicamento est\u00e1 o Brasil, Ar\u00e1bia Saudita, Bulg\u00e1ria, Col\u00f4mbia, S\u00e9rvia, Argentina, Chile, Col\u00f4mbia, Equador, El Salvador, Honduras, Kuwait, Panam\u00e1, Paraguai, S\u00e9rvia, Eslov\u00e1quia, \u00c1frica do Sul, Emirados \u00c1rabes Unidos e Uruguai.<\/p>\n<p style=\"text-align: justify;\">Segundo o fundo soberano russo, o rem\u00e9dio foi registrado em 29 de maio no pa\u00eds e j\u00e1 foi utilizado para o tratamento da doen\u00e7a causada pelo novo coronav\u00edrus em mais de 70 regi\u00f5es da R\u00fassia, e adquirido pela Bielorr\u00fassia, Bol\u00edvia, Cazaquist\u00e3o, Quirguist\u00e3o, Turcomenist\u00e3o e Uzbequist\u00e3o.<\/p>\n<p style=\"text-align: justify;\">O medicamento tamb\u00e9m foi aprovado pelos reguladores de Europa, Oriente M\u00e9dio e \u00c1sia, e para ser utilizado no Brasil, precisa receber o aval da Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa). De acordo com Kirill Dmitriev, diretor-geral do fundo soberano russo, o Avifavir \u00e9 de tr\u00eas a quatro vezes mais barato que o Remdesivir, medicamento usado contra a covid-19 que tamb\u00e9m \u00e9 baseado em favipiravir e produzido nos Estados Unidos.<\/p>\n<p style=\"text-align: justify;\">&#8220;Quando registramos o primeiro medicamento contra coronav\u00edrus no mundo baseado em favipiravir, havia muito ceticismo, pois as pessoas estavam se perguntando como poder\u00edamos registr\u00e1-lo quando o Jap\u00e3o ainda n\u00e3o o havia registrado&#8221;, afirmou Dmitriev.<\/p>\n<p style=\"text-align: justify;\">Os resultados dos testes cl\u00ednicos p\u00f3s-registro mostraram que pacientes tratados com Avifavir se recuperaram mais rapidamente dos sintomas da covid-19, j\u00e1 que em 30% dos casos o coronav\u00edrus foi eliminado em um est\u00e1gio inicial.<\/p>\n<p style=\"text-align: justify;\">Fonte: Viagora<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nesta quinta-feira (24), o fundo soberano da R\u00fassia e o grupo farmac\u00eautico KhimRar, sediado em Moscou, anunciou que foi firmado um acordo para a venda de um medicamento antiviral contra a Covid-19 para 17 pa\u00edses, entre ele o Brasil. De acordo com o fundo soberano da R\u00fassia, a Avifavir \u00e9 a primeira droga baseada em &hellip;<\/p>\n","protected":false},"author":2,"featured_media":58152,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_2648258775420054_1618374048415101":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[113,384],"tags":[6670,5689,6671,6672,4520],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil\" \/>\n<meta property=\"og:description\" content=\"Nesta quinta-feira (24), o fundo soberano da R\u00fassia e o grupo farmac\u00eautico KhimRar, sediado em Moscou, anunciou que foi firmado um acordo para a venda de um medicamento antiviral contra a Covid-19 para 17 pa\u00edses, entre ele o Brasil. De acordo com o fundo soberano da R\u00fassia, a Avifavir \u00e9 a primeira droga baseada em &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/\" \/>\n<meta property=\"og:site_name\" content=\"Portal NPM\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-24T21:30:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"170\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genival Barbosa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genival Barbosa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/\",\"url\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/\",\"name\":\"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil\",\"isPartOf\":{\"@id\":\"https:\/\/portalnpm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg\",\"datePublished\":\"2020-09-24T21:30:31+00:00\",\"dateModified\":\"2020-09-24T21:30:31+00:00\",\"author\":{\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294\"},\"breadcrumb\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#primaryimage\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg\",\"width\":275,\"height\":170},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/portalnpm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/portalnpm.com\/#website\",\"url\":\"https:\/\/portalnpm.com\/\",\"name\":\"Portal NPM\",\"description\":\"Not\u00edcias em Primeira M\u00e3o\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/portalnpm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294\",\"name\":\"Genival Barbosa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg\",\"caption\":\"Genival Barbosa\"},\"url\":\"https:\/\/portalnpm.com\/index.php\/author\/genival\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/","og_locale":"pt_BR","og_type":"article","og_title":"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil","og_description":"Nesta quinta-feira (24), o fundo soberano da R\u00fassia e o grupo farmac\u00eautico KhimRar, sediado em Moscou, anunciou que foi firmado um acordo para a venda de um medicamento antiviral contra a Covid-19 para 17 pa\u00edses, entre ele o Brasil. De acordo com o fundo soberano da R\u00fassia, a Avifavir \u00e9 a primeira droga baseada em &hellip;","og_url":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/","og_site_name":"Portal NPM","article_published_time":"2020-09-24T21:30:31+00:00","og_image":[{"width":275,"height":170,"url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg","type":"image\/jpeg"}],"author":"Genival Barbosa","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Genival Barbosa","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/","url":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/","name":"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil","isPartOf":{"@id":"https:\/\/portalnpm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#primaryimage"},"image":{"@id":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#primaryimage"},"thumbnailUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg","datePublished":"2020-09-24T21:30:31+00:00","dateModified":"2020-09-24T21:30:31+00:00","author":{"@id":"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294"},"breadcrumb":{"@id":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#primaryimage","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg","width":275,"height":170},{"@type":"BreadcrumbList","@id":"https:\/\/portalnpm.com\/index.php\/2020\/09\/24\/russia-faz-acordo-para-oferecer-remedio-contra-a-covid-19-ao-brasil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/portalnpm.com\/"},{"@type":"ListItem","position":2,"name":"R\u00fassia faz acordo para oferecer rem\u00e9dio contra a Covid-19 ao Brasil"}]},{"@type":"WebSite","@id":"https:\/\/portalnpm.com\/#website","url":"https:\/\/portalnpm.com\/","name":"Portal NPM","description":"Not\u00edcias em Primeira M\u00e3o","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/portalnpm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294","name":"Genival Barbosa","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/image\/","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg","caption":"Genival Barbosa"},"url":"https:\/\/portalnpm.com\/index.php\/author\/genival\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/exame-laboratorio-coronavirus2-1900x900_c-1900x900_c-1-1900x900_c-275x170-1.jpg","_links":{"self":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/58151"}],"collection":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/comments?post=58151"}],"version-history":[{"count":0,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/58151\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media\/58152"}],"wp:attachment":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media?parent=58151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/categories?post=58151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/tags?post=58151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}